B
oston— Anchor Line Partners and Alloy Properties have announced two significant leases totaling over 67,000 square feet across their Greater Boston life sciences portfolio. This move highlights the resilience of well-positioned assets in a challenging biotech market.
Lantheus, a radiopharmaceutical company at the forefront of diagnostic innovation, has signed a 41,000-square-foot lease at The Core @ Crosby in Bedford, MA. This marks a major milestone for the repositioned campus and solidifies its position as a regional hub for life sciences.
The second lease, covering 26,000 square feet, was signed at The Core @ Waltham, a growing four-building complex spanning 360,000 square feet. Together, these leases demonstrate the appeal of modern campuses in Boston's top suburban biotech clusters.
"Our ability to attract high-quality tenants like Lantheus reflects the strength of well-located assets," said Andrew Maher, Co-Founder and Managing Partner of Anchor Line Partners. "Through our partnerships with Alloy Properties, we deliver flexible life sciences environments where companies can thrive."
The Core @ Crosby has undergone a comprehensive transformation, featuring new amenities such as a café, state-of-the-art conference facilities, a fitness center, and an expansive outdoor deck designed for collaboration and wellness.
The Core @ Waltham continues to attract influential biotech tenants with its modern infrastructure, outdoor gathering areas, and on-site amenities. The recent lease builds on the property's growing role in the Route 128 life sciences corridor.
Lantheus was represented by Cushman & Wakefield in the transaction. Anchor Line Partners and Alloy Properties have been successful collaborators in acquiring and repositioning life sciences campuses throughout Greater Boston, focusing on location, adaptability, and tenant experience. These new leases demonstrate strong demand for modern biotech space when it is well-located, amenitized, and tailored to meet evolving company needs.
